Intranasal administration of delta sleep-inducing peptide increases P300.
Hruz
P
P
Zechner
S
S
Heimberg
D
D
Hobi
V
V
Schönenberger
G A
GA
Scheffler
K
K
Müller-Spahn
F
F
Seifritz
E
E
D000281:Administration, Intranasal; D000328:Adult; D018592:Cross-Over Studies; D003701:Delta Sleep-Inducing Peptide / Q000008:administration & dosage*; D004311:Double-Blind Method; D018913:Event-Related Potentials, P300 / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009293:Opioid-Related Disorders / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy
D003701:Delta Sleep-Inducing Peptide